Health
The Benefit of Resuming Use of the J&J COVID-19 Vaccine – University of Utah Health Care
The CDC and the FDA recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. After carefully reviewing the data,…
May 07, 2021 10:00 AM
Author:
Kylene Metzger
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended restarting use of the Johnson & Johnson vaccine on April 23, 2021, after a temporary pause. The pause followed reports of a rare adverse event called thrombosis with thrombocytopenia syndrome (TTS), or vaccine-induced thrombotic thrombocytopenia (VITT), which causes blood clots with low platelets among a small number of people, mostly women younger…
-
General9 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General12 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business9 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News11 hours agoSurgeon partner of former premier to testify over his patient’s death